WASHINGTON – The Food and Drug Administration approved a new vaccine to protect people age 11 to 55 against bacterial meningitis, which is rare but potentially deadly and debilitating. The French company sanofi pasteur received approval from the federal agency to manufacture the vaccine Menactra… Read More
Comments for: FDA approves vaccine for bacterial meningitis
FDA approves vaccine for bacterial meningitis
You may also like
FDA approves vaccine for bacterial meningitis